At Day One, we recognize that shifting priorities can result in a change in focus and direction for biotechnology and pharmaceutical development programs. Our unique business model, ability to engage in various deal structures, and our deep and diverse drug development expertise make us the partner of choice for companies looking to ensure existing development programs with potential benefit to children with cancer can be effectively re‑targeted and accelerated.
Together we can change the future of childhood cancer
Day One is a world-class drug development partner to the pediatric oncology community.
Partnering with the pediatric oncology community
We recognize that the physicians and scientists who directly study the biology and genetics of pediatric cancers are in the best position to see where opportunities exist for new medicines. Physicians and scientists, like you, who care for children with cancer, and research the underlying biology, inherently know where the greatest unmet needs are – and often have promising theories on how to best solve them. We’d like to help you do just that.
With our expertise and creativity in drug development, at Day One we stand ready to serve and partner with the pediatric oncology community to advance new therapies into the clinic and through the development and approval process.
If you have a research and development idea you would like to discuss, please contact us at email@example.com.
Important information for patients and parents
If you or a loved one is fighting cancer, please see our clinical trials section for information that may be valuable to you. Then speak with your doctor to see if a Day One clinical trial may be the right treatment option for you and your family.
Partner with us to expedite your most promising biopharma programs
To learn more, please contact us at